Vivimed Labs slumps despite FIPB approval to raise funds

The company will raise around Rs 15.75 crore through issue of warrants

Image
SI Reporter Mumbai
Last Updated : Jun 09 2015 | 12:38 PM IST
Shares of Vivimed Labs were down 10% at Rs 185 despite the company's annoucement that the Foreign Investment Promotion Board(FIPB), Department of Economic Affairs, Ministry of Finance, Government of India vide its letter dated May 29, 2015 has approved raising of funds through issue of warrants.

The approval is for issuance of 500,000 warrants with an option to apply for and be allotted equal number of equity shares, of the company to M/s KITARA PIIN 1102, Mauritius, the release said.

The proposed issuance of warrants is to be made at an issue price of Rs 315/- (which includes a premium of Rs 305/- per equity share). The FDI inflow by the foreign investor is expected to be around Rs 15.75 crore, the release added.

The stock opened at Rs 190 and touched a low of Rs 185. At 12:35PM, over 472,000 shares were traded on both the stock exchanges.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 09 2015 | 12:35 PM IST

Next Story